MCKENZIE TONKS: Open Payments
NPI 1619698750 · MIDVALE, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$633 in 23 payments from 11 companies in 2025. Trend: 2023 $1,522 · 2024 $1,818 · 2025 $633
Food & beverage: $633
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 2 | $154 |
| Incyte Corporation | 1 | $138 |
| Novartis Pharmaceuticals Corporation | 5 | $109 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 3 | $50 |
| Amgen Inc. | 2 | $42 |
| ABBVIE INC. | 2 | $37 |
| Janssen Biotech, Inc. | 2 | $34 |
| PFIZER INC. | 1 | $21 |
| Lilly USA, LLC | 1 | $20 |
| Galderma Laboratories, L.P. | 1 | $16 |
Products named: Bimzelx, OPZELURA, COSENTYX, ILUMYA, Rhapsido, OTEZLA, SKYRIZI, TREMFYA.
Industry payments across UT — which companies pay providers there.
